- Category
- Micro (2021-22)
- Udyam number
- UDYAM-DL-10-0021295

Mediglen Pharmaceuticals Private Limited
About Mediglen Pharmaceuticals Private Limited
Data last updated:
Mediglen Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 09 November 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24290DL2021PTC389513. Its GSTIN is 10AAPCM1578B1ZR (Bihar).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors Mayank Kumar and Rakesh Kumar.
Its last annual general meeting (AGM) was held on 16 August 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Plot No – 12 13 & 14 Kh No – 20/21 & 21 F/F Ranaji Encl Ph 2 Nangali Dariy, Delhi, India – 110043.
Mediglen Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-10-0021295).
Company details
Recognitions & Rankings of Mediglen Pharmaceuticals
Contact details
Mediglen Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No – 12 13 & 14 Kh No – 20/21 & 21 F/F Ranaji Encl Ph 2 Nangali Dariy, Delhi, India – 110043
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Mediglen Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Mediglen Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Mediglen Pharmaceuticals Private Limited, buy the company report.
Financials of Mediglen Pharmaceuticals Private Limited
FY 2023 filings availableMediglen Pharmaceuticals Private Limited reported revenue of ₹2,120 (down 51% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue fell 51% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Mediglen Pharmaceuticals Private Limited, buy the company report.
Board of directors of Mediglen Pharmaceuticals Private Limited
Mediglen Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mayank Kumar Also directs: Careclub Mayank Foundation | Director | 09 Nov 2021 | 5 Years 0 Months | Current |
| Rakesh Kumar Also directs: Careclub Mayank Foundation | Director | 09 Nov 2021 | 5 Years 0 Months | Current |
Legal cases
No court or tribunal cases involving Mediglen Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mediglen Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Mediglen Pharmaceuticals Private Limited has 1 active EPFO establishment as of Nov 12, 2026.
GST
Mediglen Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAPCM1578B1ZR | Bihar | Active | 26 Nov 2021 |
To see the full GST registrations and return filing status of Mediglen Pharmaceuticals Private Limited, buy the company report.
Recent activity
Mediglen Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Mayank Kumar was appointed as Director on 09 Nov 2021.
Frequently asked questions
Mediglen Pharmaceuticals is an active private limited company based in Delhi, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 09 November 2021 (5+ years old) and is registered under CIN U24290DL2021PTC389513.
Mediglen Pharmaceuticals has 2 current directors:
- Mayank Kumar - Director
- Rakesh Kumar - Director
The latest financial statements of Mediglen Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 16 August 2023. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Mediglen Pharmaceuticals is 10AAPCM1578B1ZR, registered in Bihar.
The CIN (Corporate Identification Number) of Mediglen Pharmaceuticals is U24290DL2021PTC389513. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mediglen Pharmaceuticals was incorporated on 09 November 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
Mayank Kumar was appointed as Director on 09 Nov 2021. Rakesh Kumar was appointed as Director on 09 Nov 2021.
Yes, Mediglen Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-10-0021295).
The registered office of Mediglen Pharmaceuticals is at Plot No – 12 13 & 14 Kh No – 2021 & 21 FF Ranaji Encl Ph 2 Nangali Dariy, Delhi, India – 110043.
Mediglen Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.

